133 related articles for article (PubMed ID: 8534928)
1. Suramin blocks binding of interleukin-4 to its receptors on human tumor cells and interleukin-4-induced mitogenic response.
Leland P; Obiri N; Aggarwal BB; Puri RK
Oncol Res; 1995; 7(5):227-35. PubMed ID: 8534928
[TBL] [Abstract][Full Text] [Related]
2. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells.
Obiri NI; Puri RK
Oncol Res; 1994; 6(9):419-27. PubMed ID: 7703528
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13.
Serve H; Oelmann E; Herweg A; Oberberg D; Serve S; Reufi B; Mücke C; Minty A; Thiel E; Berdel WE
Cancer Res; 1996 Aug; 56(15):3583-8. PubMed ID: 8758930
[TBL] [Abstract][Full Text] [Related]
4. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
[TBL] [Abstract][Full Text] [Related]
5. Gangliosides interact with interleukin-4 and inhibit interleukin-4-stimulated helper T-cell proliferation.
Chu JW; Sharom FJ
Immunology; 1995 Mar; 84(3):396-403. PubMed ID: 7751022
[TBL] [Abstract][Full Text] [Related]
6. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
7. Suramin prevents binding of interleukin 2 to its cell surface receptor: a possible mechanism for immunosuppression.
Mills GB; Zhang N; May C; Hill M; Chung A
Cancer Res; 1990 May; 50(10):3036-42. PubMed ID: 1692253
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4.
Morisaki T; Yuzuki DH; Lin RT; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 1992 Nov; 52(21):6059-65. PubMed ID: 1394231
[TBL] [Abstract][Full Text] [Related]
9. IL-4 blocks the up-regulation of IL-2 receptors induced by IL-2 in normal human B cells.
Lee HK; Xia X; Choi YS
J Immunol; 1990 May; 144(9):3431-6. PubMed ID: 2329278
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation.
Hidaka H; Ishiko T; Furuhashi T; Kamohara H; Suzuki S; Miyazaki M; Ikeda O; Mita S; Setoguchi T; Ogawa M
Cancer; 2002 Sep; 95(6):1206-14. PubMed ID: 12216086
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain.
Obiri NI; Husain SR; Debinski W; Puri RK
Clin Cancer Res; 1996 Oct; 2(10):1743-9. PubMed ID: 9816125
[TBL] [Abstract][Full Text] [Related]
12. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
13. Identification of a soluble, high affinity human interleukin 4 binding protein in normal human urine.
Christie G; Dacey I; Weston BJ
Cytokine; 1995 May; 7(4):305-10. PubMed ID: 8589259
[TBL] [Abstract][Full Text] [Related]
14. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation.
Atamas SP; Choi J; Yurovsky VV; White B
J Immunol; 1996 Jan; 156(2):435-41. PubMed ID: 8543791
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
Gooch JL; Lee AV; Yee D
Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
[TBL] [Abstract][Full Text] [Related]
16. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor.
Feng N; Schnyder B; Vonderschmitt DJ; Ryffel B; Lutz RA
J Recept Signal Transduct Res; 1995; 15(7-8):931-49. PubMed ID: 8673724
[TBL] [Abstract][Full Text] [Related]
17. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.
Taetle R; Dos Santos B; Akamatsu K; Koishihara Y; Ohsugi Y
Clin Cancer Res; 1996 Feb; 2(2):253-9. PubMed ID: 9816167
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
Feng N; Lugli SM; Schnyder B; Gauchat JF; Graber P; Schlagenhauf E; Schnarr B; Wiederkehr-Adam M; Duschl A; Heim MH; Lutz RA; Moser R
Lab Invest; 1998 May; 78(5):591-602. PubMed ID: 9605184
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative effect of interleukin-1 on human ovarian carcinoma cell line (NIH:OVCAR-3).
Kilian PL; Kaffka KL; Biondi DA; Lipman JM; Benjamin WR; Feldman D; Campen CA
Cancer Res; 1991 Apr; 51(7):1823-8. PubMed ID: 1825935
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-positive human epithelial ovarian carcinoma cells respond to the antitumor drug suramin with increased proliferation: possible insight into ER and epidermal growth factor signaling interactions in ovarian cancer.
Kalli KR; Bradley SV; Fuchshuber S; Conover CA
Gynecol Oncol; 2004 Sep; 94(3):705-12. PubMed ID: 15350362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]